|
|
|
|
| LEADER |
07671cam a2201033Mi 4500 |
| 001 |
koha001009859 |
| 003 |
OCoLC |
| 005 |
20231122154837.0 |
| 006 |
m d |
| 007 |
cr ||||||||||| |
| 008 |
180219s2018 gw fobd z001 0 eng d |
| 010 |
|
|
|a 2018001061
|
| 035 |
|
|
|a koha001009859
|
| 040 |
|
|
|a DEGRU
|b eng
|e rda
|e pn
|c DEGRU
|d YDX
|d OCLCF
|d N$T
|d OCLCQ
|d OCLCO
|d AU@
|d U3W
|d OCLCO
|d UAB
|d OCLCO
|d UKAHL
|d UX1
|d OCLCQ
|d UWW
|d VT2
|d USU
|d OCLCO
|d OCLCQ
|d OCLCA
|d WSL
|d K6U
|d OCLCA
|d QGK
|d EBLCP
|d UEJ
|d OCLCO
|
| 019 |
|
|
|a 1023531282
|a 1030229267
|a 1031883721
|a 1082337144
|a 1087473977
|a 1096395673
|a 1104675824
|a 1228552386
|
| 020 |
|
|
|a 9783110470734
|
| 020 |
|
|
|a 311047073X
|
| 020 |
|
|
|a 9783110470741
|
| 020 |
|
|
|a 3110470748
|
| 020 |
|
|
|a 3110469901
|
| 020 |
|
|
|a 9783110469905
|
| 020 |
|
|
|z 9783110469844
|
| 020 |
|
|
|z 3110469847
|
| 020 |
|
|
|z 9783110469905
|q (EPUB)
|
| 024 |
7 |
|
|a 10.1515/9783110470734
|2 doi
|
| 050 |
|
4 |
|a RS431.A64
|
| 060 |
|
4 |
|a W1
|b ME9611AW v.18 2018
|
| 060 |
|
4 |
|a QV 290
|
| 072 |
|
7 |
|a MED012000
|2 bisacsh
|
| 072 |
|
7 |
|a MED071000
|2 bisacsh
|
| 072 |
|
7 |
|a MED072000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI013020
|2 bisacsh
|
| 072 |
|
7 |
|a SCI013030
|2 bisacsh
|
| 080 |
|
|
|a 616
|
| 082 |
0 |
4 |
|a 615.7/98
|2 23
|
| 049 |
|
|
|a MAIN
|
| 245 |
0 |
0 |
|a Metallo-drugs
|b development and action of anticancer agents
|c edited by Astrid Sigel, Helmut Sigel, Eva Freisinger, and Roland K.O. Sigel.
|
| 264 |
|
1 |
|a Berlin ;
|a Boston
|b Walter de Gruyter GmbH,
|c [2018]
|
| 264 |
|
4 |
|c ©2018
|
| 300 |
|
|
|a 1 online resource (588 pages)
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Metal ions in life sciences,
|x 1559-0836 ;
|v volume 18
|
| 505 |
0 |
0 |
|g About the editors --
|g Historical development and perspectives of the series /
|r Astrid Sigel, Helmut Sigel, Roland K.O. Sigel --
|g Preface to volume 18 /
|r Astrid Sigel, Helmut Sigel, Eva Freisinger, Roland K.O. Sigel --
|g Contributors to volume 18. --
|g 1.
|t Cisplatin and oxaliplatin : our current understanding of their actions /
|r Imogen A. Riddell, Stephen J. Lippard --
|g 2.
|t Polynuclear platinum complexes : structural diversity and DNA binding /
|r Viktor Brabec, Jana Kasparkova, Vijay Menon, Nicholas P. Farrell --
|g 3.
|t Platinum(IV) prodrugs /
|r V. Venkatesh, Peter J. Sadler --
|g 4.
|t Metalloglycomics /
|r Nicholas P. Farrell, Anil K. Gorle, Erica J. Peterson, Susan J. Berners-Price --
|g 5.
|t The deceptively similar ruthenium(III) drug candidates KP1019 and NAMI-A have different actions : what did we learn in the past 30 years? /
|r Enzo Alessio, Luigi Messori --
|g 6.
|t Multinuclear organometallic ruthenium-arene complexes for cancer therapy /
|r Maria V. Babak, Wee Han Ang --
|g 7.
|t Medicinal chemistry of gold anticancer metallodrugs /
|r Angela Casini, Raymond Wai-Yin Sun, Ingo Ott --
|g 8.
|t Coordination complexes of titanium(IV) for anticancer therapy /
|r Edit Y. Tshuva, Maya Miller --
|g 9.
|t Health benefits of vanadium and its potential as an anticancer agent /
|r Debbie C. Crans, Lining Yang, Allison Haase, Xiaogai Yang --
|g 10.
|t Gallium complexes as anticancer drugs /
|r Christopher R. Chitambar --
|g 11.
|t Non-covalent metallo-drugs : using shape to target DNA and RNA junctions and other nucleic acid structures /
|r Lucia Cardo, Michael J. Lucia --
|g 12.
|t Nucleic acid quadruplexes and metallo-drugs /
|r Ramon Vilar --
|g 13.
|t Antitumor metallodrugs that target proteins /
|r Matthew P. Sullivan, Hannah U. Holtkamp, Christian G. Hartinger --
|g 14.
|t Metallointercalators and metalloinsertors : structural requirements for DNA recognition and anticancer activity /
|r Ulrich Schatzschneider --
|g 15.
|t Iron and its role in cancer defense : a double-edged sword /
|r Frank Thévenod --
|g 16.
|t Copper complexes in cancer therapy /
|r Delphine Denoyer, Sharnel A.S. Clatworthy, Michael A. Cater --
|g 17.
|t Targeting zinc(II) signalling to prevent cancer /
|r Silvia Ziliotto, Olivia Ogle,Kathryn M. Taylor --
|g Subject index.
|
| 520 |
|
|
|a Volume 18 centers on biological, medicinal inorganic chemistry. The serendipitous discovery of the antitumor activity of cis-diamminodichloroplatinum(II) (cisplatin) by Barnett Rosenberg in the 1960s is a landmark in metallodrug-based chemotherapy. The success of cisplatin in the clinic, followed by oxaliplatin and carboplatin, along with their drawbacks relating mainly to resistance development and severe toxicity, initiated research on polynuclear platinum complexes and on Pt(IV) complexes as prodrugs. Furthermore, the indicated shortcomings led to the exploration of other transition and main group metal ions, among them Ru(II/III), Au(I/III), Ti(IV), V(IV/V), and Ga(III) including also the essential metal ions Fe(II/III), Cu(I/II), and Zn(II). Ionic as well as covalent and non-covalent interactions between structurally very different complexes and biomolecules like nucleic acids, proteins, and carbohydrates are studied and discussed with regard to their possible anticancer actions. Hence, MILS-18 summarizes the research at the forefront of medicinal inorganic chemistry, including studies on the next-generation, tailor-made anticancer drugs. All this and more is treated in an authoritative and timely manner in the 17 stimulating chapters of this book, written by 39 internationally recognized experts from 10 nations (from the US via Europe to China and Australia). The impact of this vibrant research area is manifested by more than 2700 references, nearly 150 illustrations (more than half in color) and several comprehensive tables. Metallo-Drugs: Development and Action of Anticancer Agents is an essential resource for scientists working in the wide range from enzymology, material sciences, analytical, organic, and inorganic biochemistry all the way through to medicine including the clinic ... not forgetting that it also provides excellent information for teaching.
|
| 546 |
|
|
|a In English.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (publisher's Web site, viewed 19. Feb 2018).
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 653 |
|
0 |
|a Organoplatinum compounds
|x Therapeutic use.
|
| 653 |
|
0 |
|a Antineoplastic agents.
|
| 653 |
|
0 |
|a Pharmaceutical chemistry.
|
| 653 |
|
0 |
|a Cisplatin.
|
| 653 |
1 |
2 |
|a Organoplatinum Compounds
|x therapeutic use
|
| 653 |
2 |
2 |
|a Antineoplastic Agents
|
| 653 |
2 |
2 |
|a Cisplatin
|
| 653 |
|
2 |
|a Chemistry, Pharmaceutical
|
| 653 |
|
6 |
|a Composés organoplatiniques
|x Emploi en thérapeutique.
|
| 653 |
|
6 |
|a Anticancéreux.
|
| 653 |
|
6 |
|a Chimie pharmaceutique.
|
| 653 |
|
6 |
|a Cisplatine.
|
| 653 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 653 |
|
7 |
|a Antineoplastic agents.
|2 fast
|0 (OCoLC)fst00810595
|
| 653 |
|
7 |
|a Organoplatinum compounds
|x Therapeutic use.
|2 fast
|0 (OCoLC)fst01048008
|
| 653 |
|
7 |
|a Pharmaceutical chemistry.
|2 fast
|0 (OCoLC)fst01060115
|
| 655 |
|
4 |
|a EBSCO eBooks
|
| 700 |
1 |
|
|a Alessio, Enzo.
|
| 700 |
1 |
|
|a Ang, Wee Han.
|
| 700 |
1 |
|
|a Babak, Maria V.
|
| 700 |
1 |
|
|a Berners-Price, Susan.
|
| 700 |
1 |
|
|a Brabec, Victor.
|
| 700 |
1 |
|
|a Casini, A.
|
| 700 |
1 |
|
|a Farrell, Nicholas P.
|
| 700 |
1 |
|
|a Freisinger, Eva,
|
| 700 |
1 |
|
|a Gorle, Anil K.
|
| 700 |
1 |
|
|a Kasparkova, Jana.
|
| 700 |
1 |
|
|a Lippard, Stephen J.
|
| 700 |
1 |
|
|a Menon, Vijay.
|
| 700 |
1 |
|
|a Messori, Luigi.
|
| 700 |
1 |
|
|a Peterson, Erica J.
|
| 700 |
1 |
|
|a Riddell, Imogen.
|
| 700 |
1 |
|
|a Sadler, Peter J.
|
| 700 |
1 |
|
|a Sigel, Astrid,
|
| 700 |
1 |
|
|a Sigel, Helmut,
|
| 700 |
1 |
|
|a Sigel, Roland K. O.,
|
| 700 |
1 |
|
|a Venkatesh, V.
|
| 776 |
0 |
|
|c EPUB
|z 9783110469905
|
| 776 |
0 |
8 |
|i Print version:
|z 9783110469844
|w (DLC) 2018001061
|w (OCoLC)1019838900
|
| 830 |
|
0 |
|a Metal ions in life sciences ;
|v v. 18.
|x 1559-0836
|
| 856 |
4 |
0 |
|u https://www.lib.tsu.ru/mminfo/2023/EBSCO/1710663.pdf
|
| 999 |
|
|
|c 1009859
|d 1009859
|
